-The Times of India NEW DELHI: In a significant move ensuring safety and efficacy of medicines, the health ministry has banned around 350 fixed dose combination (FDC) drugs that were widely available in the market till now. These medicines include FDCs based on codine, used in popular cough syrups like Phensedyl and Corex. The government has decided to prohibit manufacturing and sale of these medicines because they were found to be "irrational"...
More »SEARCH RESULT
India Assures the US It Will Not Issue Compulsory Licences on Medicines -Amit Sengupta
-TheWire.in The government appears bent on decisively abandoning the earlier consensus of adherence to public health goals. In what is widely being hailed as an extraordinary victory for the multinational pharmaceutical industry over the Indian government, the US-India Business Council (USIBC), in its submission to the United States Trade Representative (USTR), reports that the Indian government has “privately assured” the industry that it would not use compulsory licences (CLs) for commercial purposes....
More »Cap profits, cut drug prices: Panel -Sushmi Dey
-The Times of India NEW DELHI: In a move that could significantly bring down prices of expensive medicines, a high-level committee has recommended capping of trade margins for costly drugs at 35% of MRP (maximum retail price). The recommendations - part of a report submitted by an inter-ministerial committee - have been put in the public domain by the Department of Pharmaceuticals, inviting comments on the suggestions. The committee was set up...
More »Green nod leeway for 'white' industries
-The Telegraph New Delhi: The Union environment ministry has reclassified industries depending on their pollution potential, ranging from 60 "red" category units prohibited from ecologically fragile and protected areas to 36 "white" industries that will not require any environmental clearance. The list released today after a year-long internal exercise is intended to appropriately reflect the pollution potential of India's diverse industrial units taking into account their emissions, effluents, hazardous wastes and consumption...
More »Policy shame: sick, rare and ignored -Shilpi Bhattacharya
-The Hindu If the Indian government is serious about its commitment to realise the rights of its citizens to universal and equitable health care, it cannot ignore rare diseases. The draft National Health Policy, 2015, makes no mention of them Rare diseases are a diverse set of over 7,000 different conditions that afflict an estimated 1 in 20 Indians and 350 million people worldwide. Put simply, it means that every bus on...
More »